Exosome-Based Solutions for Niche Environments and Applications
Legal Citation
Summary of the Inventive Concept
The inventive concept adapts mesenchymal stem cell-derived exosomes for specialized uses in high-security environments, disaster relief, extreme weather conditions, and remote locations, ensuring targeted and effective treatment of immune-mediated inflammatory diseases.
Background and Problem Solved
The original patent disclosed the use of exosomes for treating immune-mediated inflammatory diseases. However, it did not address the specific challenges and requirements of niche environments and applications. The new inventive concept solves this problem by developing tailored solutions for these unique scenarios.
Detailed Description of the Inventive Concept
The inventive concept comprises four main aspects: (1) a secure, encrypted system for administering exosomes in high-security environments; (2) a portable, waterproof composition for disaster relief; (3) a temperature-stable formulation for extreme weather conditions; and (4) a kit with a solar-powered refrigeration unit for remote, off-grid locations. These specialized variations enable the effective treatment of immune-mediated inflammatory diseases in scenarios where conventional solutions are inadequate.
Novelty and Inventive Step
The new claims introduce novel, non-obvious features that distinguish them from the original patent. These include the use of secure, encrypted communication channels, portable and waterproof packaging, temperature-stable formulations, and solar-powered refrigeration units. These innovations provide a significant inventive step, enabling the effective treatment of immune-mediated inflammatory diseases in niche environments and applications.
Alternative Embodiments and Variations
Alternative embodiments may include using different encryption protocols, varying the composition's packaging materials, or incorporating additional features for remote monitoring and tracking. These variations can ensure broad conceptual coverage and adaptability to diverse scenarios.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the pharmaceutical and biotechnology industries, particularly in the areas of disaster relief, high-security medical services, and remote or extreme environment healthcare. Target markets may include government agencies, NGOs, and private companies operating in these niches.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biotechnology and medical therapeutics, specifically focusing on exosome-based treatments for inflammatory diseases, with expertise in pharmaceutical formulation, delivery systems, and medical device engineering
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degrees in biotechnology or biomedical engineering, experienced in stem cell research, exosome characterization, drug delivery mechanisms, and medical product development with knowledge of pharmaceutical packaging and environmental adaptation strategies
Obviousness Rationale
A person skilled in the art would recognize that the source patent's exosome technology provides a foundational framework that can be readily adapted to specialized environments through predictable engineering modifications. The PTD's variations represent logical extensions of the original exosome delivery method, applying standard pharmaceutical engineering principles to address contextual challenges. These adaptations involve well-understood techniques in packaging, temperature stabilization, and secure transmission that would be immediately apparent to a skilled practitioner seeking to expand the utility of mesenchymal stem cell-derived exosomes.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,575 |
|---|---|
| Title | Mesenchymal stem cell-derived exosomes and their uses |
| Assignee(s) | Ono Pharmaceutical Co., Ltd. |